Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bioneer Corp (064550) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10100
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and reagents, RNAi, enzymes, protein expression and purification, ladders and markers, yeast genome-wide library, drug target and toxicity identification services, buffer and sequencing reagent and plastic consumables. It also offers equipment, such as, protein synthesis and nucleic acid extraction system, PCR systems, Real-Time PCR systems, sample preparation systems, centrifuge and vortex mixer and electrophoresis system. Its molecular diagnostic products include human diagnostic kits, veterinary diagnostic kits, MDx instruments and diagnostic reagent technologies. Bioneer is headquartered in Daejeon, South Korea.

Bioneer Corp (064550) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bioneer Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bioneer Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bioneer Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bioneer Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
Sanofi Enters Into Research Agreement With Bioneer 12
Licensing Agreements 13
Yuhan Enters into Licensing Agreement with Bioneer 13
Equity Offering 14
Bioneer Raises USD15.6 Million in Rights Offering of Shares 14
Bioneer to Raise USD4.3 Million in Private Placement of Shares 15
Bioneer Raises USD8.5 Million in Private Placement of Shares 16
Bioneer Raises USD1.9 Million in Private Placement of Shares 17
Debt Offering 18
Bioneer Completes Private Placement Of Fourth Bonds Due 2016 For US$3 Million 18
Bioneer Completes Private Placement Of Third Bonds Due 2015 For US$3 Million 19
Bioneer Corp – Key Competitors 20
Bioneer Corp – Key Employees 21
Bioneer Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Bioneer Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bioneer Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bioneer Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Bioneer Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bioneer Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
Sanofi Enters Into Research Agreement With Bioneer 12
Yuhan Enters into Licensing Agreement with Bioneer 13
Bioneer Raises USD15.6 Million in Rights Offering of Shares 14
Bioneer to Raise USD4.3 Million in Private Placement of Shares 15
Bioneer Raises USD8.5 Million in Private Placement of Shares 16
Bioneer Raises USD1.9 Million in Private Placement of Shares 17
Bioneer Completes Private Placement Of Fourth Bonds Due 2016 For US$3 Million 18
Bioneer Completes Private Placement Of Third Bonds Due 2015 For US$3 Million 19
Bioneer Corp, Key Competitors 20
Bioneer Corp, Key Employees 21
Bioneer Corp, Subsidiaries 22

List of Figures
Bioneer Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bioneer Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bioneer Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rohto Pharmaceutical Co Ltd (4527):企業の財務・戦略的SWOT分析
    Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Usha Martin Limited:企業の戦略・SWOT・財務情報
    Usha Martin Limited - Strategy, SWOT and Corporate Finance Report Summary Usha Martin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Huge China Holdings Limited (428):企業の財務・戦略的SWOT分析
    Huge China Holdings Limited (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Automatic Data Processing Inc (ADP):企業の財務・戦略的SWOT分析
    Automatic Data Processing Inc (ADP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Blue Energy Ltd (BUL):企業の財務・戦略的SWOT分析
    Summary Blue Energy Ltd (BEL) is an oil and gas company that provides exploration and development services. The company provides exploration and production of coal seam gas and conventional oil, and gas resources in Australia. Its projects portfolio includes Carpentaria basin, Bowen basin, galilee b …
  • Eidgenossische Technische Hochschule Zurich-医療機器分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • John Wood Group Plc (WG.):企業の財務・戦略的SWOT分析
    John Wood Group Plc (WG.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • DXI Energy Inc (DXI):石油・ガス:M&Aディール及び事業提携情報
    Summary DXI Energy Inc (DXI Energy), formerly Dejour Energy Inc is an upstream oil and gas company. The company undertakes the business of oil and gas exploration, distribution and production. It explores for oil and gas properties in regions of Colorado and British Columbia. DXI Energy operates pro …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Torrent Power Limited:企業の戦略・SWOT・財務分析
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ION Geophysical Corporation (IO)-石油・ガス分野:企業M&A・提携分析
    Summary ION Geophysical Corporation (ION) is a provider of seismic solutions. It offers advanced seismic data acquisition equipment, software, and seismic processing and planning services to the global oil and gas industry. The company acquires, process and interpret seismic data from seismic survey …
  • Prime Healthcare Services Inc:企業のM&A・事業提携・投資動向
    Prime Healthcare Services Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prime Healthcare Services Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Alabama Power Co:電力:M&Aディール及び事業提携情報
    Summary Alabama Power Co (Alabama Power), a subsidiary of Southern Company, is a vertically-integrated utility that undertakes the generation, transmission, distribution, procurement and sale of electricity. It generates electricity from coal, hydro, natural gas, oil and nuclear sources. Alabama Pow …
  • Medworxx Inc-医療機器分野:企業M&A・提携分析
    Summary Medworxx Inc (Medworxx), a subsidiary of Aptean Inc is an information technology solution provider that offers software solutions for patient flow, compliance, and education. The company’s software products include patient throughput review software, clinical criteria software, forms and ass …
  • Trimedyne Inc (TMED):企業の戦略的SWOT分析
    Trimedyne Inc (TMED) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Air Products and Chemicals Inc (APD)-石油・ガス分野:企業M&A・提携分析
    Summary Air Products and Chemicals Inc (Air Products) is an industrial gases company. It provides a portfolio of products, services, and solutions that include atmospheric, process and specialty gases, electronics and performance materials, and equipment. The company supplies oxygen, nitrogen, argon …
  • University of Illinois-製薬・医療分野:企業M&A・提携分析
    Summary University of Illinois (UOL) is a university that offers undergraduate, graduate, and professional programs. The university offers online and continuing education programs such as undergraduate and graduate online degrees. It provides research activities in the areas of alternative, compleme …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆